Performic Acid Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Performic Acid Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)


The global Performic Acid (PFA) market is poised for substantial growth, with an anticipated CAGR of 6% to 7% between 2024 and 2031, according to the latest research by Fairfield Market Research. The increasing demand for Performic Acid in the chemical, medical, and food industries is driving this growth.

Key Highlights:
• Versatile Disinfectant: Performic Acid is widely used in the medical and food industries for disinfecting equipment. It effectively combats viruses, microscopic fungi, bacterial spores, and other microorganisms. Its non-toxic breakdown products, primarily carbon dioxide, oxygen, and water, contribute to its appeal as a sterilizer.

Driving Factors for Performic Acid Demand:
• Growing Food Industry Demand: The primary driver of the market is the rising demand from the food industry. Performic Acid is used as a disinfectant and oxidizing agent in food and medical applications, and it has recently become commercially available for wastewater disinfection. High quality and environmental acceptability are significant factors contributing to increased demand.
• Medical Industry Growth: The growth of the medical industry, including the need for hospital beds, ICUs, and hygiene awareness, has led to increased demand for Performic Acid. It is used in hospitals, pharmaceuticals, and other healthcare sectors for microbial control and surface cleaning.
• Environmental-Friendly Disinfectant: Performic Acid is an environmentally friendly oxidizing biocide used in various disinfection applications, including wastewater treatment and surface cleaning in industrial settings.

APAC Performic Acid Market Outlook:

The Asia Pacific region, including countries such as China, Indonesia, India, Australia, Japan, Korea, and Singapore, has witnessed a significant uptick in Performic Acid demand. The product's exemption from residual value in the food and beverage industry, as it breaks down into harmless components, has contributed to its growing popularity.

Performic Acid is used to destroy bacteria and break down organic matter in medical waste, making it crucial for managing pathological and drug waste. These properties are expected to impact the growth of the Asia Pacific market positively.

Europe Demand Outlook for Performic Acid:

Europe, with countries like Germany, France, and Italy experiencing significant growth in the food and chemical industries, has seen increased demand for Performic Acid. It is in high demand in sectors such as chemical processing and food and beverage.

In Europe, chemical alternatives like physical water treatment, UV disinfection, and membrane filtration are gaining traction for water purification. Performic Acid plays a pivotal role in the clarification, disinfection, and purification of brackish water and wastewater in the region.

Key Manufacturers and Suppliers:

Leading manufacturers and suppliers in the Performic Acid market include Hangzhou Dayangchem Co. Limited, Sagachem Ltd, Parchem, Akos Consulting and Solution, Henan Bon Industrial Co. Ltd., Evonik Industries, among others. These key players are capitalizing on emerging opportunities, with a focus on acquisitions, collaborations, and scaling up production.

With a significant growth trajectory driven by the medical industry's expansion, especially in countries like China and India, the Asian-Pacific region is at the forefront of Performic Acid market development.

Market Segmenatation:

By Application
• Disinfectant
• Sterilizer
• Sterilant
• Others

By End-Use
• Food industry
• Medical industry
• Water treatment
• Paper and Pulp
• Others

By Region
• North America
• Latin America
• Europe
• East Asia
• South Asia Pacific
• Middle East and Africa

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.


1. Executive Summary
1.1. Global OTC Scar Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global OTC Scar Treatment Market Outlook, 2018 – 2031
3.1. Global OTC Scar Treatment Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
3.1.1. Key Highlights
3.1.1.1. Topical Scar Products
3.1.1.1.1. Gels
3.1.1.1.2. Creams/Ointments
3.1.1.1.3. Oils
3.1.1.1.4. Sheets
3.1.1.2. Others
3.2. Global OTC Scar Treatment Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
3.2.1. Key Highlights
3.2.1.1. Atrophic Scars
3.2.1.2. Hypertrophic Scars and Keloids
3.2.1.3. Contractures
3.2.1.4. Burns
3.2.1.5. Stretch Marks
3.3. Global OTC Scar Treatment Market Outlook, by Distribution Channe, Value (US$ Bn), 2018 – 2031
3.3.1. Key Highlights
3.3.1.1. Hospitals Pharmacies
3.3.1.2. Retail Pharmacies
3.3.1.3. E-Commerce
3.4. Global OTC Scar Treatment Market Outlook, by Region, Value (US$ Bn), 2018 – 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America OTC Scar Treatment Market Outlook, 2018 – 2031
4.1. North America OTC Scar Treatment Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
4.1.1. Key Highlights
4.1.1.1. Topical Scar Products
4.1.1.1.1. Gels
4.1.1.1.2. Creams/Ointments
4.1.1.1.3. Oils
4.1.1.1.4. Sheets
4.1.1.2. Others
4.2. North America OTC Scar Treatment Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
4.2.1. Key Highlights
4.2.1.1. Atrophic Scars
4.2.1.2. Hypertrophic Scars and Keloids
4.2.1.3. Contractures
4.2.1.4. Burns
4.2.1.5. Stretch Marks
4.3. North America OTC Scar Treatment Market Outlook, by Distribution Channe, Value (US$ Bn), 2018 – 2031
4.3.1. Key Highlights
4.3.1.1. Hospitals Pharmacies
4.3.1.2. Retail Pharmacies
4.3.1.3. E-Commerce
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America OTC Scar Treatment Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
4.4.1. Key Highlights
4.4.1.1. U.S. OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
4.4.1.2. U.S. OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
4.4.1.3. U.S. OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
4.4.1.4. Canada OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
4.4.1.5. Canada OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
4.4.1.6. Canada OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe OTC Scar Treatment Market Outlook, 2018 – 2031
5.1. Europe OTC Scar Treatment Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
5.1.1. Key Highlights
5.1.1.1. Topical Scar Products
5.1.1.1.1. Gels
5.1.1.1.2. Creams/Ointments
5.1.1.1.3. Oils
5.1.1.1.4. Sheets
5.1.1.2. Others
5.2. Europe OTC Scar Treatment Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
5.2.1. Key Highlights
5.2.1.1. Atrophic Scars
5.2.1.2. Hypertrophic Scars and Keloids
5.2.1.3. Contractures
5.2.1.4. Burns
5.2.1.5. Stretch Marks
5.3. Europe OTC Scar Treatment Market Outlook, by Distribution Channe, Value (US$ Bn), 2018 – 2031
5.3.1. Key Highlights
5.3.1.1. Hospitals Pharmacies
5.3.1.2. Retail Pharmacies
5.3.1.3. E-Commerce
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe OTC Scar Treatment Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
5.4.1. Key Highlights
5.4.1.1. Germany OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
5.4.1.2. Germany OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
5.4.1.3. Germany OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
5.4.1.4. U.K. OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
5.4.1.5. U.K. OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
5.4.1.6. U.K. OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
5.4.1.7. France OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
5.4.1.8. France OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
5.4.1.9. France OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
5.4.1.10. Italy OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
5.4.1.11. Italy OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
5.4.1.12. Italy OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
5.4.1.13. Turkey OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
5.4.1.14. Turkey OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
5.4.1.15. Turkey OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
5.4.1.16. Russia OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
5.4.1.17. Russia OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
5.4.1.18. Russia OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
5.4.1.19. Rest of Europe OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
5.4.1.20. Rest of Europe OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
5.4.1.21. Rest of Europe OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific OTC Scar Treatment Market Outlook, 2018 – 2031
6.1. Asia Pacific OTC Scar Treatment Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
6.1.1. Key Highlights
6.1.1.1. Topical Scar Products
6.1.1.1.1. Gels
6.1.1.1.2. Creams/Ointments
6.1.1.1.3. Oils
6.1.1.1.4. Sheets
6.1.1.2. Others
6.2. Asia Pacific OTC Scar Treatment Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
6.2.1. Key Highlights
6.2.1.1. Atrophic Scars
6.2.1.2. Hypertrophic Scars and Keloids
6.2.1.3. Contractures
6.2.1.4. Burns
6.2.1.5. Stretch Marks
6.3. Asia Pacific OTC Scar Treatment Market Outlook, by Distribution Channe, Value (US$ Bn), 2018 – 2031
6.3.1. Key Highlights
6.3.1.1. Hospitals Pharmacies
6.3.1.2. Retail Pharmacies
6.3.1.3. E-Commerce
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific OTC Scar Treatment Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
6.4.1. Key Highlights
6.4.1.1. China OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
6.4.1.2. China OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
6.4.1.3. China OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
6.4.1.4. Japan OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
6.4.1.5. Japan OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
6.4.1.6. Japan OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
6.4.1.7. South Korea OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
6.4.1.8. South Korea OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
6.4.1.9. South Korea OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
6.4.1.10. India OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
6.4.1.11. India OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
6.4.1.12. India OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
6.4.1.13. Southeast Asia OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
6.4.1.14. Southeast Asia OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
6.4.1.15. Southeast Asia OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
6.4.1.16. Rest of Asia Pacific OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
6.4.1.17. Rest of Asia Pacific OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
6.4.1.18. Rest of Asia Pacific OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America OTC Scar Treatment Market Outlook, 2018 – 2031
7.1. Latin America OTC Scar Treatment Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
7.1.1. Key Highlights
7.1.1.1. Topical Scar Products
7.1.1.1.1. Gels
7.1.1.1.2. Creams/Ointments
7.1.1.1.3. Oils
7.1.1.1.4. Sheets
7.1.1.2. Others
7.2. Latin America OTC Scar Treatment Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
7.2.1. Key Highlights
7.2.1.1. Atrophic Scars
7.2.1.2. Hypertrophic Scars and Keloids
7.2.1.3. Contractures
7.2.1.4. Burns
7.2.1.5. Stretch Marks
7.3. Latin America OTC Scar Treatment Market Outlook, by Distribution Channe, Value (US$ Bn), 2018 – 2031
7.3.1. Key Highlights
7.3.1.1. Hospitals Pharmacies
7.3.1.2. Retail Pharmacies
7.3.1.3. E-Commerce
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America OTC Scar Treatment Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
7.4.1. Key Highlights
7.4.1.1. Brazil OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
7.4.1.2. Brazil OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
7.4.1.3. Brazil OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
7.4.1.4. Mexico OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
7.4.1.5. Mexico OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
7.4.1.6. Mexico OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
7.4.1.7. Argentina OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
7.4.1.8. Argentina OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
7.4.1.9. Argentina OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
7.4.1.10. Rest of Latin America OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
7.4.1.11. Rest of Latin America OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
7.4.1.12. Rest of Latin America OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa OTC Scar Treatment Market Outlook, 2018 – 2031
8.1. Middle East & Africa OTC Scar Treatment Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
8.1.1. Key Highlights
8.1.1.1. Topical Scar Products
8.1.1.1.1. Gels
8.1.1.1.2. Creams/Ointments
8.1.1.1.3. Oils
8.1.1.1.4. Sheets
8.1.1.2. Others
8.2. Middle East & Africa OTC Scar Treatment Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
8.2.1. Key Highlights
8.2.1.1. Atrophic Scars
8.2.1.2. Hypertrophic Scars and Keloids
8.2.1.3. Contractures
8.2.1.4. Burns
8.2.1.5. Stretch Marks
8.3. Middle East & Africa OTC Scar Treatment Market Outlook, by Distribution Channe, Value (US$ Bn), 2018 – 2031
8.3.1. Key Highlights
8.3.1.1. Hospitals Pharmacies
8.3.1.2. Retail Pharmacies
8.3.1.3. E-Commerce
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa OTC Scar Treatment Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
8.4.1. Key Highlights
8.4.1.1. GCC OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
8.4.1.2. GCC OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
8.4.1.3. GCC OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
8.4.1.4. South Africa OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
8.4.1.5. South Africa OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
8.4.1.6. South Africa OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
8.4.1.7. Egypt OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
8.4.1.8. Egypt OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
8.4.1.9. Egypt OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
8.4.1.10. Nigeria OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
8.4.1.11. Nigeria OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
8.4.1.12. Nigeria OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
8.4.1.13. Rest of Middle East & Africa OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 – 2031
8.4.1.14. Rest of Middle East & Africa OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 – 2031
8.4.1.15. Rest of Middle East & Africa OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 – 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Segment 3 vs by Application Heat map
9.2. Manufacturer vs by Application Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Smith & Nephew PLC
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Merz Inc
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Enaltus LLC
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Occulus Innovative Sciences Inc.
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. CCA Industries Inc
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Cynosure Inc
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Avita Medical Limited
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Lumenis
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Syneron Medical Ltd.
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Nutramarks Inc.
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Mölnlycke Health Care
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Pacific World Corporation
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. Valeant Pharmaceuticals International Inc
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. Shanghai Fosun Pharmaceuticals Ltd. (AC. Alma Lasers)
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. SkinCeuticals
9.5.15.1. Company Overview
9.5.15.2. Product Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
9.5.16. A. Menarini Singapore Pte. Ltd.
9.5.16.1. Company Overview
9.5.16.2. Product Portfolio
9.5.16.3. Financial Overview
9.5.16.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings